Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

1724studies indexed776with human data107registered trials1479carry a numeric findingLibrarian added 0 studies today
Showing 14 studiesSortNewest indexed
B
grade
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.
P21 (P021) · Nature medicine · 2026 · ObservationalTop journal
Over half of the patients treated with daraxonrasib showed genomic alterations linked to resistance, suggesting the need for combination therapies to address these changes.
59% of patients (26 of 44) showed treatment-emergent genomic alterations in the RAS signaling pathway.
Showing 14 of 14